Company registration number:
W.R. Evans Healthcare Limited
for the Year Ended 30 November 2022
W.R. Evans Healthcare Limited
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Financial Statements |
W.R. Evans Healthcare Limited
Company Information
Directors |
Mrs A J Cattee Mr G A Tims Mr P Cattee |
Registered office |
|
Auditors |
|
W.R. Evans Healthcare Limited
(Registration number: 00664125)
Balance Sheet as at 30 November 2022
Note |
2022 |
2021 |
|
Fixed assets |
|||
Investments |
|
|
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Retained earnings |
( |
( |
|
Shareholders' funds |
|
|
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
......................................... |
W.R. Evans Healthcare Limited
Notes to the Financial Statements for the Year Ended 30 November 2022
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
These financial statements were authorised for issue by the
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention .
The financial statements are prepared in sterling, which is the functional currency of the entity.
Audit report
Exemption from preparing group accounts
The company has taken advantage of the exemption in section 400 of the Companies Act 2006 from the requirement to prepare consolidated financial statements, as it and its subsidiary undertakings are included in by full consolidation in the consolidated financial statements of its ultimate parent company, PCT Healthcare (Holdings) Limited.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
W.R. Evans Healthcare Limited
Notes to the Financial Statements for the Year Ended 30 November 2022
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Investments |
2022 |
2021 |
|
Investments in subsidiaries |
|
|
Subsidiaries |
£ |
Cost or valuation |
|
At 1 December 2021 |
|
Provision |
|
At 1 December 2021 |
|
Carrying amount |
|
At 30 November 2022 |
|
At 30 November 2021 |
|
Details of undertakings
Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:
Undertaking |
Registered office |
Holding |
Proportion of voting rights and shares held |
|
2022 |
2021 |
|||
Subsidiary undertakings |
||||
|
11 Manchester Road, Walkden Manchester M28 3NS England |
|
|
|
|
11 Manchester Road, Walkden, Manchester M28 3NS England |
|
|
|
W.R. Evans Healthcare Limited
Notes to the Financial Statements for the Year Ended 30 November 2022
Subsidiary undertakings |
Sawley Investments Ltd The principal activity of Sawley Investments Ltd is |
The Manor Drug Company (Nottingham) Ltd The principal activity of The Manor Drug Company (Nottingham) Ltd is |
Parent and ultimate parent undertaking |
The company's immediate parent is
The most senior parent entity producing publicly available financial statements is